Heartburn drug recalled over cancer fears

By Justin George Varghese
Updated October 9 2019 - 7:43am, first published 7:39am
US regulators warned of a potentially dangerous contaminant in heartburn drug Zantac.
US regulators warned of a potentially dangerous contaminant in heartburn drug Zantac.

GlaxoSmithKline says it is recalling the popular heartburn medicine Zantac in all markets as a "precaution", days after the US Food and Drug Administration found "unacceptable" levels of probable cancer-causing impurity in the drug.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Nowra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.